Global Pharma Solutions

What Global Pharma Solutions does

Global Pharma Solutions is a privately held pharmaceutical regulatory consulting firm founded in 2003 by Margaret Jenkins and headquartered in Brighton East, Melbourne, Australia. The firm provides project-based regulatory affairs, clinical development, quality assurance, and pharmacovigilance services to pharmaceutical, biotechnology, medical device, OTC, complementary medicine, and cosmetic product companies. Its service portfolio covers product development from bench through registration and market launch, regulatory strategy and submissions across Australia, New Zealand, Asia Pacific, the United States, the United Kingdom, Europe, Japan, and Canada, clinical trial setup and management, GMP auditing, adverse event reporting, and full lifecycle management including post-approval variations and line extensions. A specialised Compliance Rescue service uses a proprietary AAA framework (Analyse, Assess, Approve) for remediation of at-risk submissions.

The firm operates without any proprietary technology platform, software product, or API; its core technology is human-expert consulting grounded in collective regulatory and scientific expertise. The team comprises approximately 11 named professionals with 10-35 years of individual industry experience (totalling over 115 years combined), spanning drug discovery, CMC, QA, regulatory strategy, clinical operations, and medical writing across prescription, biotech, biosimilar, vaccine, stem cell, gene therapy, and orphan product modalities.

The business model is professional services consulting on a quote-based, project-specific pricing structure with no publicly disclosed rate cards or tiers. Go-to-market is sales-led: direct client engagement through the company website, contact forms, Calendly strategy-call booking, phone and email outreach, supplemented by content marketing through industry blog posts on regulatory topics and a LinkedIn professional presence. Customer segments span both small start-ups lacking internal regulatory capacity and large multinational organisations seeking supplementary regulatory support, with no external private equity or venture capital backing evidenced.

Name

Global Pharma Solutions

Legal name

Global Pharma Solutions

Website

https://globalpharmasolutions.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory Consulting

NAICS

Other Management Consulting Services (541618)

SIC

Services-Management Consulting Services (8742)

akta.pro industry

PRIMARYHLAIABAJ

Generic ANDA/Regulatory Affairs & Submissions

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

SECONDARYHLAGAHAM

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

• Regulatory affairs consulting
• Pharmaceutical submissions
• Clinical development services
• Pharmacovigilance consulting
• Medical device registration

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Regulatory Affairs Consulting Services: Project-based consulting engagements covering regulatory strategy, dossier preparation, regulatory submissions, and lifecycle management for pharmaceutical products across global markets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Global Pharma Solutions is a pharmaceutical consulting firm that delivers regulatory affairs, clinical development, quality assurance, and pharmacovigilance services for prescription medicines, OTC and complementary medicines, biologics, vaccines, biosimilars, gene therapies, stem cell therapies, medical devices, and cosmetics. Engagements span product development from bench through registration, dossier preparation, regulatory submissions across multiple jurisdictions (TGA, FDA, EMA, MHRA, PMDA, Health Canada), lifecycle management, and the proprietary Compliance Rescue AAA service for at-risk submissions.

Product overview

Global Pharma Solutions offers a comprehensive suite of regulatory affairs, clinical development, quality, and pharmacovigilance consulting services for the pharmaceutical, biotechnology, and medical device industries. Their core services include regulatory strategy and submissions, clinical development support, quality assurance, and pharmacovigilance. The company also provides specialized offerings such as the Compliance Rescue AAA service (Analyse, Assess, Approve) for emergency compliance situations, and medical writing services for regulatory and clinical documentation. Services span multiple jurisdictions including Australia, New Zealand, Asia Pacific, United States, United Kingdom, and Europe. The company was founded in 2003 and specializes in prescription medicines, OTC medicines, complementary medicines, medical devices, and cosmetics.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory Affairs Consulting Expert regulatory affairs consulting covering strategy development, dossier preparation, and submission management across global markets including Australia, New Zealand, Asia Pacific, US, UK, and Europe. Targeted at pharmaceutical, biotechnology, and medical device companies.
• Clinical Development Services Clinical operations support including clinical trial setup and management, BA/BE study support, protocol development, ethics submissions, and complete clinical program management. Targeted at pharmaceutical and biotechnology companies.
• Quality Assurance Quality management services including quality control, quality assurance, auditing, GMP compliance, and pre-approval inspection preparation for pharmaceutical products. Targeted at pharmaceutical manufacturers requiring quality system support.
• Pharmacovigilance Services Ongoing pharmacovigilance support including adverse event reporting, compliance maintenance, safety data processing, and KPI tracking. Targeted at pharmaceutical companies with marketed products requiring post-approval safety surveillance.
• Product Development Pharmaceutical product development services spanning from bench through registration and market launch, covering cell therapies, prescription medicines, OTC, complementary medicines, medical devices, and cosmetics. Targeted at pharmaceutical and biotechnology companies developing new products.
• Compliance Rescue (AAA Service) A diagnostic compliance rescue service employing the AAA framework: Analyse (due diligence and gap identification), Assess (risk evaluation and strategy development), and Approve (remediation implementation and project management to ensure compliance and approval). Targeted at pharmaceutical and medical device companies with at-risk regulatory submissions.
• Medical Writing Services Medical and regulatory writing services including protocol development, ethics submissions, clinical study reports, publication planning, peer-reviewed manuscripts, and regulatory switch submissions. Targeted at pharmaceutical and biotechnology companies requiring regulatory and clinical documentation.
• Regulatory Submissions and Lifecycle Management

Quantifiable outcome

• Successfully supported companies in achieving regulatory approvals and market registrations across global markets

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Global Partner CompaniescoreStrategic or Co-development PartnerThe company partners with companies globally to provide regulatory affairs, clinical development, quality, and pharmacovigilance support. Partnerships involve collaborative relationships for product registration and market authorisation across multiple jurisdictions.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• WuXi AppTec: WuXi AppTec is a large Asia-headquartered CRO/CDMO offering preclinical, clinical, regulatory, and laboratory services to global pharma. Its regulatory affairs practice overlaps with Global Pharma Solutions' offering, particularly for APAC-based sponsors, but at materially larger scale.
• Cencora: Cencora (formerly AmerisourceBergen) is a global pharmaceutical services company that owns PharmaLex and offers regulatory consulting alongside distribution and specialty pharmacy operations. It addresses the same client needs as Global Pharma Solutions through its consulting arm.
• ICON plc: ICON plc is a leading global CRO providing clinical, regulatory, and laboratory services to pharmaceutical and medical device companies. Its regulatory consulting function overlaps with Global Pharma Solutions' core service line but operates as part of a much broader portfolio.
• Parexel International: Parexel is one of the largest global CROs offering regulatory, clinical development, and pharmacovigilance services to pharma and biotech sponsors. It is a broad incumbent in the same end-markets as Global Pharma Solutions but delivers scale-driven, multi-service programmes rather than boutique specialised advisory.
• Charles River Laboratories: Charles River Laboratories is a major CRO offering research models, preclinical and clinical support, manufacturing, and regulatory consulting. Its regulatory affairs arm competes for the same client budgets as Global Pharma Solutions but is bundled within a much wider scientific-services platform.

Direct peers

• Pharmaxi Consulting: Pharmaxi is a privately held regulatory affairs and pharmacovigilance consultancy serving pharmaceutical and biotech companies. As a smaller specialised competitor with a similar service mix, it is comparable to Global Pharma Solutions in scale and positioning.
• PharmaLex (Cencora): PharmaLex, now part of Cencora (formerly AmerisourceBergen), provides regulatory affairs, quality, and pharmacovigilance consulting across global markets. Its service scope and client base (pharma and biotech sponsors needing multi-jurisdictional submissions) directly mirrors Global Pharma Solutions' offering, with considerably broader geographic footprint and headcount.
• ProPharma Group: ProPharma Group is a privately held life sciences consulting firm offering regulatory affairs, clinical research, quality compliance, and pharmacovigilance services to pharma and biotech companies. It is one of the closest comparables to Global Pharma Solutions in business model and service mix, though at significantly larger scale.

Regional players

• Avance Clinical: Avance Clinical is Australia's largest locally headquartered CRO offering clinical and regulatory services to biotech sponsors in APAC/US. It competes for overlapping client budgets in the same Australian market but with a clinical-trial-centric offering rather than regulatory advisory focus.

Emerging players

• Proventa International: Proventa International is a niche consulting firm providing regulatory affairs, quality, and pharmacovigilance advisory to pharma and biotech clients across multiple markets. It is comparable in service scope and target market but operates at a smaller scale with fewer service lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/GlobalPharmaSol
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/global-pharma-solutions

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Pharma Solutions